Healthcare -
Biotechnology - NASDAQ - US
$ 38.6444
-0.118 %
$ 10.8 B
Market Cap
21.96
P/E
EXEL - STOCK-BASED COMPENSATION
Stock-based Compensation EXEL - Exelixis, Inc.
93.8 M
LAST VALUE
-6.60%
2 YEAR CAGR
10.64%
5 YEAR CAGR
25.09%
10 YEAR CAGR